In the present study, the discrepancy between anti-obesity action and inhibitory action of pancreatic lipase by orlistat could not sufficiently be clarified; therefore, this discrepancy is needed to clarify in future studies. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.